[HTML][HTML] CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens
…, NN Gorgani, NM Kljavin, JM Elliott, L Diehl… - Cell, 2006 - cell.com
The complement system serves an important role in clearance of pathogens, immune complexes,
and apoptotic cells present in the circulation. Complement fragments deposited on the …
and apoptotic cells present in the circulation. Complement fragments deposited on the …
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy
…, Q Ou, S Ye, WP Lee, J Cornelius, L Diehl… - The Journal of …, 2005 - journals.aai.org
B cell immunotherapy has emerged as a mainstay in the treatment of lymphomas and
autoimmune diseases. Although the microenvironment has recently been demonstrated to play …
autoimmune diseases. Although the microenvironment has recently been demonstrated to play …
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
…, T Sai, W Lee, M Xu, P Caplazi, L Diehl… - Nature …, 2011 - nature.com
Interleukin 17C (IL-17C) is a member of the IL-17 family that is selectively induced in epithelia
by bacterial challenge and inflammatory stimuli. Here we show that IL-17C functioned in a …
by bacterial challenge and inflammatory stimuli. Here we show that IL-17C functioned in a …
[HTML][HTML] Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
…, WJ Sandborn, GW Tew, D Luca, MT Tang, L Diehl… - The Lancet, 2014 - thelancet.com
Background Etrolizumab is a humanised monoclonal antibody that selectively binds the β7
subunit of the heterodimeric integrins α4β7 and αEβ7. We aimed to assess etrolizumab in …
subunit of the heterodimeric integrins α4β7 and αEβ7. We aimed to assess etrolizumab in …
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
…, J Zhang, J Lesch, WP Lee, J Ross, L Diehl… - Nature, 2014 - nature.com
The connection between an altered gut microbiota and metabolic disorders such as obesity,
diabetes, and cardiovascular disease is well established 1 , 2 . Defects in preserving the …
diabetes, and cardiovascular disease is well established 1 , 2 . Defects in preserving the …
PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells
K Hasegawa, F Martin, G Huang, D Tumas, L Diehl… - Science, 2004 - science.org
Protein tyrosine kinases and phosphatases cooperate to regulate normal immune cell
function. We examined the role of PEST domain–enriched tyrosine phosphatase (PEP) in …
function. We examined the role of PEST domain–enriched tyrosine phosphatase (PEP) in …
A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3
…, R Noubade, M Roose-Girma, J DeVoss, L Diehl… - Nature, 2014 - nature.com
Crohn’s disease is a debilitating inflammatory bowel disease (IBD) that can involve the entire
digestive tract. A single-nucleotide polymorphism (SNP) encoding a missense variant in …
digestive tract. A single-nucleotide polymorphism (SNP) encoding a missense variant in …
Specific Btk inhibition suppresses B cell–and myeloid cell–mediated arthritis
…, J Darrow, DR Davies, LE DeForge, L Diehl… - Nature chemical …, 2011 - nature.com
Bruton's tyrosine kinase (Btk) is a therapeutic target for rheumatoid arthritis, but the cellular
and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here …
and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here …
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
…, PM Haverty, H Gilbert, WY Lin, L Diehl… - Arthritis research & …, 2014 - Springer
Introduction Rheumatoid arthritis (RA) is a complex and clinically heterogeneous autoimmune
disease. Currently, the relationship between pathogenic molecular drivers of disease in …
disease. Currently, the relationship between pathogenic molecular drivers of disease in …
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis
…, H Clark, ID Arnott, ID Penman, J Satsangi, L Diehl - Gut, 2008 - gut.bmj.com
Objective: To investigate differential intestinal gene expression in patients with ulcerative
colitis and in controls. Design: Genome-wide expression study (41 058 expression sequence …
colitis and in controls. Design: Genome-wide expression study (41 058 expression sequence …